neurotensin (8-13) has been researched along with vanoxerine in 1 studies
Studies (neurotensin (8-13)) | Trials (neurotensin (8-13)) | Recent Studies (post-2010) (neurotensin (8-13)) | Studies (vanoxerine) | Trials (vanoxerine) | Recent Studies (post-2010) (vanoxerine) |
---|---|---|---|---|---|
66 | 0 | 10 | 556 | 5 | 93 |
Protein | Taxonomy | neurotensin (8-13) (IC50) | vanoxerine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.5098 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0103 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.5513 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0969 | |
Small conductance calcium-activated potassium channel protein 2 | Rattus norvegicus (Norway rat) | 0.073 | |
Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | 0.073 | |
Small conductance calcium-activated potassium channel protein 1 | Rattus norvegicus (Norway rat) | 0.073 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0424 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.022 | |
Transporter | Rattus norvegicus (Norway rat) | 0.114 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gratton, A; Rompré, PP | 1 |
1 other study(ies) available for neurotensin (8-13) and vanoxerine
Article | Year |
---|---|
Mesencephalic microinjections of neurotensin-(1-13) and its C-terminal fragment, neurotensin-(8-13), potentiate brain stimulation reward.
Topics: Animals; Brain; Brain Mapping; Conditioning, Operant; Electric Stimulation; Mesencephalon; Microinjections; Neurotensin; Neurotransmitter Uptake Inhibitors; Peptide Fragments; Piperazines; Rats; Reward; Sensory Thresholds | 1993 |